1. Home
  2. ZURA vs BNED Comparison

ZURA vs BNED Comparison

Compare ZURA & BNED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • BNED
  • Stock Information
  • Founded
  • ZURA 2022
  • BNED 1965
  • Country
  • ZURA United States
  • BNED United States
  • Employees
  • ZURA N/A
  • BNED N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • BNED Other Specialty Stores
  • Sector
  • ZURA Health Care
  • BNED Consumer Discretionary
  • Exchange
  • ZURA Nasdaq
  • BNED Nasdaq
  • Market Cap
  • ZURA 69.9M
  • BNED 295.2M
  • IPO Year
  • ZURA N/A
  • BNED N/A
  • Fundamental
  • Price
  • ZURA $1.96
  • BNED $9.14
  • Analyst Decision
  • ZURA Buy
  • BNED
  • Analyst Count
  • ZURA 10
  • BNED 0
  • Target Price
  • ZURA $12.67
  • BNED N/A
  • AVG Volume (30 Days)
  • ZURA 292.6K
  • BNED 311.3K
  • Earning Date
  • ZURA 11-06-2025
  • BNED 09-12-2025
  • Dividend Yield
  • ZURA N/A
  • BNED N/A
  • EPS Growth
  • ZURA N/A
  • BNED N/A
  • EPS
  • ZURA N/A
  • BNED N/A
  • Revenue
  • ZURA N/A
  • BNED $1,567,800,000.00
  • Revenue This Year
  • ZURA N/A
  • BNED $2.74
  • Revenue Next Year
  • ZURA N/A
  • BNED N/A
  • P/E Ratio
  • ZURA N/A
  • BNED N/A
  • Revenue Growth
  • ZURA N/A
  • BNED N/A
  • 52 Week Low
  • ZURA $0.97
  • BNED $7.90
  • 52 Week High
  • ZURA $5.07
  • BNED $14.41
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 51.95
  • BNED 56.41
  • Support Level
  • ZURA $1.88
  • BNED $8.10
  • Resistance Level
  • ZURA $2.19
  • BNED $8.73
  • Average True Range (ATR)
  • ZURA 0.13
  • BNED 0.37
  • MACD
  • ZURA -0.04
  • BNED 0.11
  • Stochastic Oscillator
  • ZURA 17.50
  • BNED 87.77

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About BNED Barnes & Noble Education Inc

Barnes & Noble Education Inc is an operator of bookstores in college and university campuses across the United States. The company is also engaged in providing digital education services. It operates in three reportable segments that include Retail offers existing and prospective clients the flexibility of physical, virtual, or custom store solutions, and wholesale is comprised of the wholesale and virtual retail fulfillment, and support operations of the MBS subsidiary, also Corporate Services represent unallocated shared-service costs which include corporate level expenses and other governance functions, including executive functions, such as accounting, legal, treasury, information technology, and human resources. It earns majority of the revenue from Retail segment.

Share on Social Networks: